CN1067073C - 非环式核苷衍生物 - Google Patents

非环式核苷衍生物 Download PDF

Info

Publication number
CN1067073C
CN1067073C CN97192183A CN97192183A CN1067073C CN 1067073 C CN1067073 C CN 1067073C CN 97192183 A CN97192183 A CN 97192183A CN 97192183 A CN97192183 A CN 97192183A CN 1067073 C CN1067073 C CN 1067073C
Authority
CN
China
Prior art keywords
butyl
guanine
oxygen base
compound
valyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97192183A
Other languages
English (en)
Chinese (zh)
Other versions
CN1210537A (zh
Inventor
P·恩格哈德特
M·黑格堡
周晓雄
B·林德波尔格
N·G·约翰逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600614A external-priority patent/SE9600614D0/xx
Priority claimed from SE9600613A external-priority patent/SE9600613D0/xx
Application filed by Medivir AB filed Critical Medivir AB
Publication of CN1210537A publication Critical patent/CN1210537A/zh
Application granted granted Critical
Publication of CN1067073C publication Critical patent/CN1067073C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN97192183A 1996-02-16 1997-02-14 非环式核苷衍生物 Expired - Fee Related CN1067073C (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE9600613-5 1996-02-16
SE96006143 1996-02-16
SE9600614-3 1996-02-16
SE9600614A SE9600614D0 (sv) 1996-02-16 1996-02-16 Antiviral compounds
SE9600613A SE9600613D0 (sv) 1996-02-16 1996-02-16 Acyclic nucleoside derivatives
SE96006135 1996-02-16

Publications (2)

Publication Number Publication Date
CN1210537A CN1210537A (zh) 1999-03-10
CN1067073C true CN1067073C (zh) 2001-06-13

Family

ID=26662518

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97192183A Expired - Fee Related CN1067073C (zh) 1996-02-16 1997-02-14 非环式核苷衍生物

Country Status (25)

Country Link
US (5) US5869493A (enExample)
EP (2) EP0880521B1 (enExample)
JP (2) JP4171069B2 (enExample)
KR (1) KR100464692B1 (enExample)
CN (1) CN1067073C (enExample)
AR (1) AR005827A1 (enExample)
AT (2) ATE231507T1 (enExample)
AU (1) AU715062B2 (enExample)
BG (1) BG64179B1 (enExample)
CA (1) CA2243826C (enExample)
CZ (1) CZ292169B6 (enExample)
DE (2) DE69718626T2 (enExample)
DK (1) DK0888348T3 (enExample)
EA (2) EA001404B1 (enExample)
ES (2) ES2189941T3 (enExample)
HU (1) HU229865B1 (enExample)
IL (1) IL124760A (enExample)
MY (1) MY123083A (enExample)
NO (1) NO322930B1 (enExample)
NZ (1) NZ330472A (enExample)
PL (1) PL184892B1 (enExample)
SK (1) SK284613B6 (enExample)
TR (1) TR199801318T2 (enExample)
TW (1) TW533213B (enExample)
WO (2) WO1997030052A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
AU735438B2 (en) * 1996-11-12 2001-07-05 Medivir Ab Nucleosides
EP0971923B1 (en) * 1997-02-10 2002-11-06 Medivir Ab Synthesis of acyclic nucleoside derivatives
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
AU728892B2 (en) * 1997-08-15 2001-01-18 Medivir Ab Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
WO1999032490A1 (en) * 1997-12-19 1999-07-01 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
CA2522573A1 (en) * 2003-04-30 2004-11-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of famciclovir
CN101132795B (zh) 2004-12-30 2011-09-21 梅迪弗股份公司 用于hiv治疗的化合物
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
CN101033238B (zh) * 2006-03-06 2011-02-16 中国科学院上海药物研究所 嘌呤类化合物双氨基酸酯的制备方法和用途
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
MX2010000424A (es) 2007-07-09 2010-08-10 Easter Virginia Medical School Derivados de nucleosidos sustituidos con propiedades antivirales y antimicrobianas.
EP2195319A4 (en) * 2007-09-21 2011-09-14 Epiphany Biosciences Inc POLYMORPHS OF VALOMACICLOVIR
WO2011022712A1 (en) * 2009-08-21 2011-02-24 Epiphany Biosciences, Inc. Method of treating infectious mononucleosis with acylic nucleoside derivatives
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
KR101763127B1 (ko) 2015-06-23 2017-08-01 (주)농협아그로 끈끈이 엠보싱 트랩 테이프
WO2024118480A1 (en) * 2022-11-28 2024-06-06 Epiphany Biosciences Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116282A (en) 1960-04-27 1963-12-31 Upjohn Co Pyrimidine nucleosides and process
FR2040177A1 (en) 1969-01-31 1971-01-22 Robugen Gmbh 2-deoxyribosyl-uracil derivs
US3817982A (en) 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4247544A (en) 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides
US4267171A (en) 1979-07-02 1981-05-12 The Regents Of The University Of California C-5 Substituted cytosine nucleosides
JPS57146798A (en) 1981-03-06 1982-09-10 Yamasa Shoyu Co Ltd Hexosyl nucleoside derivative
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
EP0286825A3 (en) 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections
SE8701605D0 (sv) 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
DE3883374T2 (de) * 1987-10-28 1993-12-09 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
SE8704298D0 (sv) 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
SE8801729D0 (sv) 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US5284837A (en) 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
SE8802173D0 (sv) 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
FI95384C (fi) 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5874578A (en) 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (enExample) * 1993-11-18 1996-08-01 Ajinomoto Kk
US5521161A (en) 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
JP3906488B2 (ja) 1995-02-21 2007-04-18 味の素株式会社 プリン誘導体の製造方法
KR100491941B1 (ko) * 1996-01-26 2005-08-05 에프. 호프만-라 로슈 아게 푸린유도체의제조방법
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
AU1592897A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
EP0827960A1 (en) 1996-09-10 1998-03-11 Ajinomoto Co., Inc. Process for producing purine derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents

Also Published As

Publication number Publication date
JP4171069B2 (ja) 2008-10-22
ES2189941T3 (es) 2003-07-16
AU715062B2 (en) 2000-01-13
AU713916B2 (en) 1999-12-16
HUP9900680A2 (hu) 1999-06-28
EA002809B1 (ru) 2002-10-31
US20090076041A1 (en) 2009-03-19
DE69718626T2 (de) 2003-09-11
HUP9900680A3 (en) 2001-02-28
MY123083A (en) 2006-05-31
EP0888348B1 (en) 2003-01-22
DE69718619D1 (de) 2003-02-27
JP2000504720A (ja) 2000-04-18
SK284613B6 (sk) 2005-07-01
DE69718619T2 (de) 2003-08-21
WO1997030051A1 (en) 1997-08-21
EP0880521A1 (en) 1998-12-02
NO983216D0 (no) 1998-07-13
BG102647A (en) 1999-04-30
CZ232298A3 (cs) 1998-10-14
ES2189942T3 (es) 2003-07-16
IL124760A (en) 2003-09-17
EP0888348A1 (en) 1999-01-07
CZ292169B6 (cs) 2003-08-13
ATE231508T1 (de) 2003-02-15
EA200000787A1 (ru) 2001-04-23
NZ330472A (en) 2000-02-28
DK0888348T3 (da) 2003-04-14
TW533213B (en) 2003-05-21
NO983216L (no) 1998-10-13
US6576763B1 (en) 2003-06-10
DE69718626D1 (de) 2003-02-27
EA199800729A1 (ru) 1999-02-25
ATE231507T1 (de) 2003-02-15
KR19990082571A (ko) 1999-11-25
PL184892B1 (pl) 2003-01-31
AR005827A1 (es) 1999-07-14
HK1015773A1 (en) 1999-10-22
EP0880521B1 (en) 2003-01-22
PL328335A1 (en) 1999-01-18
CA2243826C (en) 2005-12-27
NO322930B1 (no) 2006-12-18
AU1818397A (en) 1997-09-02
US20120123119A1 (en) 2012-05-17
CA2243826A1 (en) 1997-08-21
JP2000504721A (ja) 2000-04-18
US5869493A (en) 1999-02-09
WO1997030052A1 (en) 1997-08-21
US6255312B1 (en) 2001-07-03
HU229865B1 (en) 2014-10-28
BG64179B1 (bg) 2004-03-31
CN1210537A (zh) 1999-03-10
EA001404B1 (ru) 2001-02-26
TR199801318T2 (xx) 1998-10-21
IL124760A0 (en) 1999-01-26
SK98598A3 (en) 1998-12-02
AU1818297A (en) 1997-09-02
US8124609B2 (en) 2012-02-28
KR100464692B1 (ko) 2005-06-21

Similar Documents

Publication Publication Date Title
CN100347185C (zh) 新的无环核苷膦酸酯衍生物,其盐及其制备方法
CN1038935C (zh) 取代的联苯吡啶酮化合物及其盐的制备方法
CN1051083C (zh) 有免疫调节活性的新的取代嘌呤基衍生物
CN1193018C (zh) 杂环衍生物及其医药用途
CN1251676C (zh) 苯基黄嘌呤衍生物
CN1179960C (zh) 吲哚衍生物和其在治疗骨质疏松中的应用以及其它应用
CN1049215C (zh) 新的苯并喹唑啉胸苷酸合成酶抑制剂的制法
CN1085556A (zh) 抗偏头痛的吲哚-3-基烷基哌嗪的4-嘧啶基和吡啶基衍生物
CN1284076A (zh) 2－芳基－8－氧代二氢嘌呤衍生物及其制备方法、含有该衍生物的药物组合物、及其中间体
CN1106017A (zh) 核苷酸膦酸酯衍生物
CN1330637A (zh) 用于治疗炎性疾病的化合物
CN1210537A (zh) 非环式核苷衍生物
CN86105664A (zh) 7-氧杂二环庚烷取代的二酰胺及其同种类的前列腺素类似物
CN1282316A (zh) 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
CN1073166A (zh) 羟肟酸衍生物
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1946405A (zh) 9h－嘌呤－2,6－二胺衍生物在治疗增殖性疾病中的应用以及新的9h－嘌呤－2,6－二胺衍生物
CN1047078A (zh) 用作兴奋性基酸神经递质拮抗物和/或钙通道阻滞剂的聚胺和多肽
CN1083059A (zh) 3-哌啶甲基羧酸酯取代的吲哚
CN1146422C (zh) 2-甲基-噻吩并-苯并二氮杂�制剂
CN1124734A (zh) 噻嗪-或硫氮杂䓬衍生物
CN1060466A (zh) 苯、吡啶和嘧啶的衍生物
CN1377353A (zh) 具有磷酸二酯酶iv抑制活性的嘌呤衍生物
CN1108657A (zh) 雪花胺衍生物、其制备方法及其作为药物的用途
CN1492859A (zh) 嘧啶无环核苷衍生物、其制备方法及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20010613

Termination date: 20150214

EXPY Termination of patent right or utility model